“Is that it? Am I cured?” is usually the first question after the pathology results come back. For most people with early-stage lung cancer, surgery offers the best chance of cure. Having had one lung cancer, though, means you need a careful plan for the years that follow. Here is how I approach it, and the evidence behind it.
Why follow-up matters
There are two separate risks after lung cancer surgery:
- Recurrence: the original cancer coming back, either in the chest or elsewhere. In a large study of 1,294 patients followed with routine CT after surgery for early-stage lung cancer, the risk of recurrence was about 6–10% per year for the first four years, falling to about 2% per year after that.1
- A second, new lung cancer: because the lungs were exposed to the same risk factors, people who have had one lung cancer are at higher risk of developing another. In the same study, new lung cancers appeared at 3–6% per year, and that risk did not fall over time.1
The first risk is why follow-up is more frequent in the early years. The second is why it continues for life.
My usual follow-up schedule
CT every 6 months
A chest CT, together with a clinic visit to review symptoms, recovery and breathing.
CT once a year
An annual chest CT, often low-dose, mainly to watch for a new lung cancer.
CT as often as every 3 months
For a more aggressive-looking cancer or lymph node involvement, I may scan more often at first.
This is close to what the major guidelines recommend. ASCO advises a chest CT, preferably with contrast and including the adrenal glands, every 6 months for the first 2 years, then a low-dose CT every year to look for new lung cancers.2 The U.S. National Comprehensive Cancer Network (NCCN) gives similar advice: a clinic visit and chest CT every 6 months for 2–3 years, then annually.3
Why I sometimes scan more often
Not every lung cancer behaves the same way. The pathology report tells me a great deal about how likely a cancer is to come back. Features that raise that risk include lymph node involvement, cancer cells in small blood or lymph vessels, and certain growth patterns. One such pattern is spread through air spaces (STAS), where small clusters of tumour cells are found in the air spaces beyond the edge of the tumour. In one study of small stage I adenocarcinomas removed by limited resection, recurrence at five years was 42.6% with STAS versus 10.9% without it.4
When I see features like these, I may tighten the schedule to a CT every 3 months for a period before stepping back to every 6 months. A follow-up plan should be tailored to your own cancer, not taken from a template.
Does CT follow-up actually help?
This has been studied directly. In the French IFCT-0302 trial, 1,775 patients who had their lung cancer completely removed were followed either with chest CT scans or with chest X-rays alone, every 6 months for 2 years, then yearly to 5 years.5
- Overall survival was similar in the two groups.
- CT found recurrences before symptoms appeared more often: 38% of recurrences were found without symptoms in the CT group, compared with 17.5% in the X-ray group.
- CT was much better at finding new lung cancers early: 82.5% of second primaries in the CT group were found before any symptoms, compared with 48% with X-rays.
A new lung cancer found early can often be treated again with surgery or focused radiation, with a real chance of cure. That is the main reason I continue an annual CT for the long term. The trade-off is that CT also finds small spots that turn out to be harmless. In the large U.S. study, a quarter of patients needed extra tests at some point for a false alarm, although serious complications from those tests were rare (0.3%).1
What is not routinely recommended
- PET scans for routine follow-up: they add radiation and cost and often give false positives. They are used if something suspicious appears.2
- Brain MRI for routine follow-up of non-small cell lung cancer without symptoms.2
- Blood tumour markers as a surveillance test.2
What you can do between scans
- Stop smoking, if you still smoke. It is never too late. In a review of early-stage lung cancer, continuing to smoke after diagnosis was linked to about twice the risk of recurrence and nearly three times the risk of death.6
- Stay active. Walking and breathing exercises help the remaining lung recover. I cover this in the recovery guide.
- Tell us about new symptoms without waiting for your next scan: a new or changing cough, coughing up blood, chest or bone pain, persistent headaches, or unexplained weight loss.
- Keep up with any additional treatment. Depending on your stage and the results of tumour testing, you may be offered chemotherapy, immunotherapy or a targeted drug after surgery. See Lung cancer treatment by stage.
Recently diagnosed, or looking for a second opinion? Read about lung cancer surgery or see the referral information.
Common questions
How often should I have a CT scan after lung cancer surgery?
Why do I need scans every year after the first two years?
Do I need a PET scan or brain MRI as part of follow-up?
What are the chances of lung cancer coming back after surgery?
Which symptoms should I report between scans?
References
- Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2013;145(1):75–82.
- Schneider BJ, Ismaila N, Aerts J, et al. Lung cancer surveillance after definitive curative-intent therapy: ASCO guideline. J Clin Oncol. 2020;38(7):753–766.
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (surveillance section).
- Kadota K, Nitadori JI, Sima CS, et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas. J Thorac Oncol. 2015;10(5):806–814.
- Westeel V, et al. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2022;23(9):1180–1188.
- Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.
